• HVE
  • Excess mortality
  • Trending
  • Calculators
    • De Covidsterfte calculator
    • With HVE from placebo to panacea

US age restrictions boosters do not apply in Europe

by Anton Theunissen | 5 Nov 2021, 14:11

↠Remarkable effectiveness study applauded in NRC Inconsistency in CBS data raises questions →
reading time

Do the safety and effectiveness data from clinical trials C4591001 support the approval of a COMIRNATY booster dose, to be used in individuals 16 years of age and older, at least 6 months after completion of the primary series? That was the first question raised in the FDA Hearing about the boosters. I give an impression of the video registration because I think that hardly anyone has watched it.

It has become a fairly long article based on a video that lasts more than 8 hours. First, the contributions that pass by during the Open Public Hearing.

The opinions in the Open Public Hearing Session

In the Open Public Hearing session, a number of experts and stakeholders (doctors and activists) each get three minutes to explain their point of view. Below is the youtube time code and most important keywords per head. It is tempting to only look at the medical status, but it is actually about the validity of the views.

Pfizer has researched the booster shots. Do the results provide the rationale to approve the booster shots for everyone aged 16 and older? (Keep in mind that the EMA approves boosters from the age of 18.)

Rajesh Gupta Ph.D. : Strongly advises against. The presence of antibodies is not a reliable target. Trials have not investigated infection. Little sense unless with the very vulnerable. Against vaccinating 16+.

Ben Newton – Approval requires 50% effectiveness, so boosters are desperately needed to stay above 50% given the decreasing effectiveness! Talks about "The right to be vaccinated" and "Every unvaccinated person has the same R0 value as an anti-vaxxer". [Is this a scientific approach...?]

Dr. Jessica Rose: Viral immunologist. Points to the sheer amount of side effects in VAERS: more than all vaccines combined in the past 10 years. Especially unacceptable for children. Variants only become more dangerous because of the booster shots. So don't do it.

Professional. Retsef Levi (URL)– Not satisfied with monitoring for side effects in Israel [research is being done, will be corrected later]. Herd immunity is not possible. Still high infection rates and mortality is increasing despite the vaccines. First determine research and strategy. Until then: don't do it!

Dr. Joseph Fraiman – Need for larger trials. Gain experience with Covid and with the vaccines. For people in their twenties, it is not possible to prove that covid is more harmful than vaccines. Too little evidence to be able to give the boosters to everyone! Also look at other medications.

Steve Kirsch – Trial showed that there were 4x as many heart attacks in vaccinated people. 20 deaths among vaccinated people; 14 in the placebo group. Vaccines cost more lives than they save. Myocarditis occurred in about 1:1000 boys. After vaccination at 1:317. After the booster, he expects 1:25. Points to fraud in the trials. Very strongly against.

Dr. David Wiseman – Politicized topic. No studies, no proper effectiveness and certainly not about the boosters. In Israel, excess mortality increases with Booster roll-out. Menstrual problems. Gene therapy should be investigated for carcinogenicity for 5-10 years. In short: too little data, too many side effects, no insight into long-term effects, especially relevant for young people. Look at existing drugs! Against.

Kermit Kubitz – Mentions advantages: "Boosters" are misnamed, normal vaccination protocols also sometimes require months between administration. Boosters protect against variants and getting sick despite being vaccinated. Boosters protect against infection, including unvaccinated people. Worldwide delivery will come from cheaper, more conventional vaccinations and Biologic E vaccines are coming [I have taken these points almost verbatim because I don't understand everything but what I do understand is not true]. But in any case: Before the boosters

Dr. Peter Doshi – If there is a Pandemic of Unvaccinated people, why a Booster? There is no research capable of side effects of third dose. Furthermore, all warning voices from doctors and scientists are dismissed as "spreading misinformation". Worrisome situation, what is the FDA doing about it? Under these circumstances: Clearly against. Too many strangers.

Dr. Michael Carome – No risk/benefit profile for the boosters. Unclear to what extent side effects increase. Protection against serious illness unclear. Quotes Lancet. More important to vaccinate poor countries. Speaks of 'highly effective'.

Kim Witczak – Goalposts continue to be moved. Trials are severely insufficient, involve several hundred people. Absurd as a basis for a global roll-out. mRNA vaccines are never designed to stop infection or eradicate the virus. False pretenses: vaccines would be better than natural immunity, people were 'bribed' to get vaccinated, demonizing unvaccinated people. Again accusation of obstruction of free speech and certainly of doctors and scientists. Side effects are huge. The biggest medical experiment ever. So against.

Lynda Dee – Scientific basis is lacking. Discusses approval protocols. So too little data.

Dr. Meg Seymour – Security research is far too small and also not representative. Only 12 patients aged 65 and over, while that is the most important group. Ages 16-17 are modeled based on the results of 18+. Three months is also too short to signal effects. Methodological objections, not scientifically justifiable. So very much against.

Kathleen Cameron – Very pro-vax, wants rapid vaccines for the elderly and communities of color. Asks for an informed decision because vaccines are important and the impact of Covid-19 is terrible so we want to do everything we can.

Beth Battaglino – Promo speech for the activities of her foundation. No opinion to be made.

Brian Hujdich – Concerned about decreasing effectiveness, especially in connection with his own foundation that deals with HIV patients. Would like extra protection for HIV patients and others with a malfunctioning immune system. Before, to inoculate everyone aged 16 years and older so that HIV patients are protected.

Dr. Paul Alexander – Strong criticism of the evaluation and monitoring. Scientific substantiation is insufficient, too short-term. "We currently do not have the safety data". Too many red flags in animal testing! So strongly against. Under no circumstances vaccinate children! Don't!

9/17/2021: FDA Advisory Board advises "conditional"

On September 17, the FDA met to vote on approving the Booster shots. To be seen on this over 8-hour Youtube video. The video is a sometimes somewhat embarrassing sequence of old men shouting at each other that they are on mute and other technical problems, but more on that later. Pfizer gives online product presentations and research results with many graphs, slides, titers and anybodies with which Americans indicate antibodies. Questions are being asked about this by FDA members. Due to lack of time, it is sometimes necessary to little room for difficult questions

Toen ik die video destijds bekeek dacht ik ‘dat wordt niks’. De tegenstemmers wezen unaniem op het gebrek aan data van veiligheid en effectiviteit – en al helemáál waar het om kinderen en jongeren ging. (Zie hierboven de steekwoorden uit die eerste adviesronde van de Open Public Hearing Session, met tijdcodes naar de YT-vid.) De teneur was uitermate negatief.

There were votes on the first request to get approval for the booster shots from the age of 16 three members for and 16 against.

Then to a second question. Plan B, so to speak: whether they could agree to booster shots for

  • people aged 65 and over
  • other high-risk groups, including people who have a high risk of infection due to their work

That turned out to be no problem at all, they voted UNANIMOUSLY IN FAVOR – which surprised me a bit after hearing the original objections.

22-9-2021: FDA conditionally allows

Five days later, on September 22, the FDA added the Booster shot to the Emergency Use Authorization for the Pfizer vaccine for the groups mentioned above.

Again in the Pfizer Fact Sheet the fixed condition that ALL serious side effects, regardless of whether the vaccine is suspected or not, must be reported.

"irrespective of attriburion"= whether you think it has to do with the vaccine or not
Note: "following vaccination" = after the vaccination has taken place (i.e. not by vaccination). In the trials, a period of 30 days applies to this.

Reporting must be done in the US to VAERS. There are research-based estimates that the underreporting in VAERS is a factor of 40. I doubt whether that factor also applies to the Covid vaccines because of the publicity surrounding the vaccines. Even if that factor is half, the conditions are not met in the US either. Apparently, this is not an obstacle to administering the product on a large scale.

4-10-2021: EMA is fine with it and promises to pay attention

After the FDA, the EMA can decide on application in Europe. The European Medicines Agency makes its recommendations for the boosters in Europe, a distinction is made between people with a weakened immune system and people with a normal immune system. She is thus leaving the age restrictions as set by the FDA.

EMA: In case of weakened immune system boosters only for vulnerable people

For the weakened, although there is no direct evidence that the ability to produce antibodies - as demonstrated with the booster - in these patients protects against COVID-19, it is expected that the extra dose could increase protection in at least some patients.

So nothing is weighed against possible side effects here, only possible effectiveness is looked at and the wish seems to be the father of expectation.

EMA promises to "continue to monitor the data that emerges on its effectiveness." What happens to the data on the side effects is not mentioned. The fact that these reports are also lagging behind in the Netherlands has now been old news.

EMA: with a normal immune system everyone from the age of 18...!?

The EMA advice. The restrictions from the FDA (only vulnerable and over 65) have been set aside.

De EMA concludeert dat voor de niet-kwetsbaren de boosterdoses mogen worden gebruikt vanaf 18 jaar en ouder. Ze vermelden wel nog dat het risico op inflammatoire hartaandoeningen of andere zeer zeldzame bijwerkingen na een booster niet bekend is en zorgvuldig wordt gecontroleerd (zie wat NL betreft de Lareb-link hierboven). Maar dan wordt in Nederland gezegd: “De EMA heeft het goedgekeurd, dus…”

EMA website: AUTHORIZED!

AUTHORISED! Not a word about mandatory reports or about conditions.

Elsewhere on the site, it is indeed reported that it is a conditional marketing authorisation "because the medicine meets an unmet medical need"; After all, it is necessary to fill the gap that is not filled by other medications. Therefore, it is not appropriate to little data on the market .

But then a nice green block with "AUTHORISED" really makes more of an impression!

Would a yellow triangle have been out of place? And not "AUTHORIZED" but "CONDITIONAL APPROVAL"?

But Pfizer already had Full Approval, didn't it...?

Anyone who reads the FDA's press release dated August 23 could understand that the Pfizer vaccine has long since been approved.

If you read a bit stricter, it says that the FDA has now approved "Comirnaty". formerly 'Pfizer-BioNTech CoOVID-19 Vaccine', the first Covid-19 vaccine.

The vaccine will also remain available (like Pfizer-BioNTech CoOVID-19 Vaccine) under Emergency Use Authorization, including 12-15 year olds and as a booster dose for immunocompromised people.

But I admit, it is very conveniently formulated and beneficial for the willingness to vaccinate.

How worrisome is it?

It doesn't make much sense to listen to the entire Q&A with Pfizer. The questioners would like to appear knowledgeable on Pfizer and ask long questions. They all invariably call each other "Doctor" which at some point takes on something colossal. Pfizer's answers are sometimes difficult to follow and yet people continue to watch with interest, presumably afraid that something is not right with their own connection. Only a technician dares to intervene a few times.

So much for the teaching, then also some entertainment. A small impression (I skip the screencam during the detailed question, at the bottom left of the screen I typed a comment here and there):

videolink: https://virusvaria.nl/wp-content/uploads/2021/11/FDA-pfizer-booster.mp4

The last hour is still informative, the members give an explanation of their vote. Het belangrijkste argument vóór is in elk geval om te zorgen voor minder besmettingen zodat de druk op de zorg afneemt. Men heeft kennelijk toch wat gemist qua bescherming tegen besmettingen.

Additional studies on this topic:

Waning Immunity after the BNT162b2 Vaccine in Israel https://www.nejm.org/doi/pdf/10.1056/NEJMoa2114228
Swedish study shows covid vaccines drop below zero efficacy on spread by about 200 days https://boriquagato.substack.com/p/swedish-study-shows-covid-vaccines?s=03
In it a link to:
Pre-print Effectiveness of Covid-19 vaccination against risk of symptomatic infection,
hospitalization, and death up to 9 months: a Swedish total-population cohort study

There was also a remarkably outspoken supporter who made himself heard a number of times:

↠previous post Next post →
Related reading pleasure:
Still pricking for people over 12: Kuipers accepts responsibility for any vaccine damage Pfizer's vaccine trial with infants and toddlers Ernesto Ramirez Jr., 17, died of myocarditis – and then...

amnesty Anne Frank antibiotics baby's Bioweapons ethics

heart failure itb we can query life expectancy Mass formation motive qaly

Spike VE WOO Bulgaria conspiracy theory Causes

John Ukraine PeterSweden RKI deferred care asmr

censorship data effectiveness iq Parliamentary inquiry rivm

UK Baseline Burkhardt journalism nocebo Excess mortality debate

alijst IC NRC Government information responsibility narrative

praise Wuhan Measures norm mortality ivermectin mdhaero

manipulation society research politics CBS lableak disinformation

communication science vaccination excess mortality statistics media

science corruption aerosols scientific integrity infection Side effects hve

Public health Children women Level Wynia Vaccination readiness

paradogma Australia Pfizer OUR Badbatches Fauci

Post-Covid opinion lockdowns filosofie foreign country Wob

sociology placebo obfuscation Gupta Germany ChatGPT

cardiovascular vitaminD Mortality Monitor privacy Repopulation Koopmans

Japan Deltavax calculator pregnancy safety thrombosis

Lawsuits Un face masks long covid Lareb Hotels ionization

fraud variegated bhakdi monkeypox Anti-VAX fear

Views (inst:8-10-'21): 1.035
↠Remarkable effectiveness study applauded in NRC Inconsistency in CBS data raises questions →

Would you like a notification e-mail with each new article?

Thanks for your interest!
Some fields are missing or incorrect!
Bijdragen aan virusvaria mag. Klik en vul zelf het bedrag in
👇
Contribute something? Please! Click here.
ðŸ‘

Face masks revisited

nov 21, 2025

Wrong models

nov 17, 2025

Important update in The Telegraph. Hello Keulemans?

nov 16, 2025

Data camouflage in NL and UK: Deltavax in two languages

nov 15, 2025

2024 compared to 2019 in age cohorts M/F

nov 2, 2025

Post-war birth waves and mortality expectations: the gray buffer of death

Oct 27, 2025

Mortality in the Netherlands per 100K in 5 years of cohorts (graphs) and Why Standard Mortality?

Oct 22, 2025

The curse of the sewer ghost deciphered: how excess mortality ended up as Covid mortality

Oct 15, 2025

Pension: an economic explanation for the rejection of the Mortality Standard

Oct 10, 2025

RIVM emphasizes the need for standard mortality model

Oct 5, 2025

The New World with Marlies Dekkers and Maarten Keulemans (Reaction)

sep 24, 2025

COVID vaccines: Costs and benefits in years of life

sep 21, 2025

« Previous Page

Contribute something? Please! Click here.

Translation


© Contact Anton Theunissen
We use a cookie bar on our website to inform you that we analyze the use. We do not use cookies for marketing purposes. (Google respects the privacy laws.)
OK
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDuurBeschrijving
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept
Aangedreven door CookieYes Logo